Annual Working Capital
$377.85 M
+$235.78 M+165.95%
December 31, 2023
Summary
- As of March 3, 2025, APGE annual working capital is $377.85 million, with the most recent change of +$235.78 million (+165.95%) on December 31, 2023.
- During the last 3 years, APGE annual working capital has risen by +$235.78 million (+165.95%).
- APGE annual working capital is now at all-time high.
Performance
APGE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$501.87 M
-$155.36 M-23.64%
September 30, 2024
Summary
- As of March 3, 2025, APGE quarterly working capital is $501.87 million, with the most recent change of -$155.36 million (-23.64%) on September 30, 2024.
- Over the past year, APGE quarterly working capital has stayed the same.
- APGE quarterly working capital is now -37.19% below its all-time high of $799.06 million, reached on March 31, 2024.
Performance
APGE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
APGE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +165.9% | 0.0% |
| 3 y3 years | +165.9% | +343.9% |
| 5 y5 years | +165.9% | +343.9% |
APGE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +165.9% | -37.2% | +343.9% |
| 5 y | 5-year | at high | +165.9% | -37.2% | +343.9% |
| alltime | all time | at high | +165.9% | -37.2% | +343.9% |
Apogee Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $501.87 M(-23.6%) |
| Jun 2024 | - | $657.24 M(-17.7%) |
| Mar 2024 | - | $799.06 M(+111.5%) |
| Dec 2023 | $377.85 M | $377.85 M(-7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $409.24 M(+262.0%) |
| Jun 2023 | - | $113.05 M(-13.6%) |
| Mar 2023 | - | $130.82 M(-7.9%) |
| Dec 2022 | $142.07 M | $142.07 M |
FAQ
- What is Apogee Therapeutics annual working capital?
- What is the all time high annual working capital for Apogee Therapeutics?
- What is Apogee Therapeutics annual working capital year-on-year change?
- What is Apogee Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Apogee Therapeutics?
- What is Apogee Therapeutics quarterly working capital year-on-year change?
What is Apogee Therapeutics annual working capital?
The current annual working capital of APGE is $377.85 M
What is the all time high annual working capital for Apogee Therapeutics?
Apogee Therapeutics all-time high annual working capital is $377.85 M
What is Apogee Therapeutics annual working capital year-on-year change?
Over the past year, APGE annual working capital has changed by +$235.78 M (+165.95%)
What is Apogee Therapeutics quarterly working capital?
The current quarterly working capital of APGE is $501.87 M
What is the all time high quarterly working capital for Apogee Therapeutics?
Apogee Therapeutics all-time high quarterly working capital is $799.06 M
What is Apogee Therapeutics quarterly working capital year-on-year change?
Over the past year, APGE quarterly working capital has changed by $0.00 (0.00%)